ContaCT

Viz.Al, Inc. · DEN170073 · 2018-02-13

ContaCT is an AI-enabled medical device from Viz.Al, Inc., listed by FDA (De Novo, DEN170073) with a decision date of 2018-02-13. Review panel: Radiology.

FDA submission numberDEN170073
PathwayDe Novo
CompanyViz.Al, Inc.
Review panel (specialty)Radiology
FDA decision date2018-02-13
DecisionUnknown
Product codeQAS
ClassificationRadiological Computer-Assisted Triage And Notification Software
Device class2
Regulation number892.2080
Review time (calendar days)137
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.